he added: �these findings show that despite the tireless work of doctors and nurses, it appears that some cancer patients are still enduring shockingly long waits to start treatment..
harvard medical school: "cgrp: a new era for migraine treatment.".
.
.
why novartis� landmark cancer drug approval is great news for bluebird.